RxDoctor Payments Data

David Shaffer

Medical Oncology · Albany, NYNPI 1487625158

Payments from drug & device makers

What this record shows

This record is dominated by education: $15 of the $15 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, E.r. Squibb & Sons, L.L.C.. That places this record below the midpoint for medical oncology clinicians in NY, where the typical reported total is $4,912.

$15in general payments, 2019–2025

Across 1 payment — averaging $15.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$15
$3,180,422in research payments, 2019–2025

Across 1,482 payments — averaging $2146.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$650K
  • Janssen Research & Development, LLC$562K
  • E.r. Squibb & Sons, L.L.C.$489K
  • Eli Lilly$453K
  • Incyte Corporation$303K
  • Merck$228K
  • plus $495K from 8 others

What the payments were for

  • Education$15100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.1$15

How this compares

$15 in reported general payments places this provider in the 5th percentile of 498 medical oncology providers in New York.

See all medical oncology providers in New York →

Other medical oncology in Albany

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →